Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker

Table 3 Clinical indexes in relation to DTL expression status in the stomach samples

Characteristics	Clinical Samples	DTL		χ²	p
Characteristics	Clinical Samples	Low(≤ 10)	High(> 10)	χ²	p
Age
> 65	97	10	30	9.2841	0.0023
≤ 65	97	32	25	9.2841	0.0023
Gender
Female	97	3	14	5.5246	0.0188
Male	97	39	41	5.5246	0.0188
Grade
High-grade STAD	97	22	32	0.3247	0.5688
Middle-grade STAD	97	20	23	0.3247	0.5688
Stage
1	97	0	1	2.3809	0.5803
2		13	20
3		25	32
4		1	35
Cancer
cancer	167	42	44	6.2267	0.0126
adjacent tissues	167	55	26	6.2267	0.0126
CD3
≤ 10%	97	10	24	4.1122	0.0426
> 10%	97	32	31	4.1122	0.0426

Statistical analysis was conducted by the chi-square test or Fisher’s exact test

ISSN: 1471-2407